Ocuphire Pharma Ownership 2024 | Who Owns Ocuphire Pharma Now?
Institutional Ownership
10.87%
Insider Ownership
7.33%
Retail Ownership
81.80%
Institutional Holders
38.00
Ocuphire Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.05% | - | 992,200 | - | - | 1,518,066 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | - | 265,854 | 31,456 | 13.42% | 406,842 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.91% | 0.02% | 223,589 | -68,396 | -23.42% | 342,091 | Jun 30, 2024 |
| RICHMOND BROTHERS, INC. | 0.78% | 0.58% | 191,304 | -36,157 | -15.90% | 292,695 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.67% | 0.01% | 163,741 | -46,200 | -22.01% | 250,524 | Jun 30, 2024 |
| BLACKROCK INC. | 0.44% | - | 106,935 | 10,221 | 10.57% | 163,610 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.41% | 0.10% | 100,000 | - | - | 153,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.29% | - | 70,473 | - | - | 107,824,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.23% | - | 56,105 | -9 | -0.02% | 85,841 | Jun 30, 2024 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.17% | 0.00% | 42,341 | - | - | 64,782 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.17% | 0.00% | 41,700 | -93,600 | -69.18% | 63,801 | Jun 30, 2024 |
| EMPOWERED FUNDS, LLC | 0.16% | 0.00% | 39,305 | 2,700 | 7.38% | 60,137 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.16% | 0.03% | 38,035 | -13,359 | -25.99% | 58,193 | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | 0.14% | 0.00% | 33,267 | - | - | 50,899 | Jun 30, 2024 |
| COMERICA BANK | 0.12% | 0.00% | 30,000 | - | - | 45,900 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.11% | - | 27,267 | -24,658 | -47.49% | 41,719,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.09% | - | 21,945 | 21,945 | 100.00% | 34,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.09% | 0.00% | 21,555 | 5,046 | 30.57% | 32,978 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.07% | 0.00% | 18,000 | - | - | 27,540 | Jun 30, 2024 |
| UBS GROUP AG | 0.06% | - | 15,703 | 1,475 | 10.37% | 24,026 | Jun 30, 2024 |
Ocuphire Pharma's largest institutional shareholder is VANGUARD GROUP INC, holding 4.05% of the company's total share outstanding, currently valued at $1.52M. The top 10 institutional shareholders own together 9.02% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RICHMOND BROTHERS, INC. | 0.78% | 0.58% | 191,304 | -36,157 | -15.90% | 292,695 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.41% | 0.10% | 100,000 | - | - | 153,000 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.16% | 0.03% | 38,035 | -13,359 | -25.99% | 58,193 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.91% | 0.02% | 223,589 | -68,396 | -23.42% | 342,091 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.67% | 0.01% | 163,741 | -46,200 | -22.01% | 250,524 | Jun 30, 2024 |
| BEDEL FINANCIAL CONSULTING, INC. | 0.06% | 0.00% | 15,000 | - | - | 22,950 | Jun 30, 2024 |
| STOKES FAMILY OFFICE, LLC | 0.05% | 0.00% | 12,120 | - | - | 18,544 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.06% | 0.00% | 13,852 | -6,766 | -32.82% | 21,194 | Jun 30, 2024 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.17% | 0.00% | 42,341 | - | - | 64,782 | Jun 30, 2024 |
| EMPOWERED FUNDS, LLC | 0.16% | 0.00% | 39,305 | 2,700 | 7.38% | 60,137 | Jun 30, 2024 |
| CARSONALLARIA WEALTH MANAGEMENT, LTD. | 0.00% | 0.00% | 1,000 | - | - | 1,530 | Jun 30, 2024 |
| COMERICA BANK | 0.12% | 0.00% | 30,000 | - | - | 45,900 | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | 0.14% | 0.00% | 33,267 | - | - | 50,899 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.17% | 0.00% | 41,700 | -93,600 | -69.18% | 63,801 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,592 | -3,784 | -51.30% | 5,496 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.07% | 0.00% | 18,000 | - | - | 27,540 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.09% | 0.00% | 21,555 | 5,046 | 30.57% | 32,978 | Jun 30, 2024 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0.00% | 0.00% | 727 | -455 | -38.49% | 1,112 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | - | 265,854 | 31,456 | 13.42% | 406,842 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.05% | - | 992,200 | - | - | 1,518,066 | Jun 30, 2024 |
The largest Ocuphire Pharma shareholder by % of total assets is RICHMOND BROTHERS, INC.. The company owns 191.30K shares of Ocuphire Pharma (OCUP), representing 0.58% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | - | 265,854 | 31,456 | 13.42% | 406,842 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.09% | - | 21,945 | 21,945 | 100.00% | 34,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.44% | - | 106,935 | 10,221 | 10.57% | 163,610 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.05% | - | 12,000 | 10,000 | 500.00% | 18,960 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.09% | 0.00% | 21,555 | 5,046 | 30.57% | 32,978 | Jun 30, 2024 |
| EMPOWERED FUNDS, LLC | 0.16% | 0.00% | 39,305 | 2,700 | 7.38% | 60,137 | Jun 30, 2024 |
| UBS GROUP AG | 0.06% | - | 15,703 | 1,475 | 10.37% | 24,026 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 213 | 213 | 100.00% | 326 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 76 | 76 | 100.00% | 116,000 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 40 | - | - | 61 | Jun 30, 2024 |
| STATE STREET CORP | 0.29% | - | 70,473 | - | - | 107,824,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.05% | - | 992,200 | - | - | 1,518,066 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.07% | 0.00% | 18,000 | - | - | 27,540 | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | 0.14% | 0.00% | 33,267 | - | - | 50,899 | Jun 30, 2024 |
| COMERICA BANK | 0.12% | 0.00% | 30,000 | - | - | 45,900 | Jun 30, 2024 |
| CARSONALLARIA WEALTH MANAGEMENT, LTD. | 0.00% | 0.00% | 1,000 | - | - | 1,530 | Jun 30, 2024 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.17% | 0.00% | 42,341 | - | - | 64,782 | Jun 30, 2024 |
| STOKES FAMILY OFFICE, LLC | 0.05% | 0.00% | 12,120 | - | - | 18,544 | Jun 30, 2024 |
| BEDEL FINANCIAL CONSULTING, INC. | 0.06% | 0.00% | 15,000 | - | - | 22,950 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.41% | 0.10% | 100,000 | - | - | 153,000 | Jun 30, 2024 |
As of Jun 30 2024, Ocuphire Pharma's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 31.46K stocks of OCUP, valued at $406.84K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAI CAPITAL MANAGEMENT | - | - | - | -223,970 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.17% | 0.00% | 41,700 | -93,600 | -69.18% | 63,801 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.91% | 0.02% | 223,589 | -68,396 | -23.42% | 342,091 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -65,911 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.67% | 0.01% | 163,741 | -46,200 | -22.01% | 250,524 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -40,814 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -36,628 | -100.00% | - | Jun 30, 2024 |
| RICHMOND BROTHERS, INC. | 0.78% | 0.58% | 191,304 | -36,157 | -15.90% | 292,695 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.11% | - | 27,267 | -24,658 | -47.49% | 41,719,000 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -19,868 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -17,752 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -17,400 | -100.00% | - | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.16% | 0.03% | 38,035 | -13,359 | -25.99% | 58,193 | Jun 30, 2024 |
| LINCOLN NATIONAL CORP | - | - | - | -11,900 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -10,545 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.06% | 0.00% | 13,852 | -6,766 | -32.82% | 21,194 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,592 | -3,784 | -51.30% | 5,496 | Jun 30, 2024 |
| TOTH FINANCIAL ADVISORY CORP | - | - | - | -1,001 | -100.00% | - | Jun 30, 2024 |
| OPTIMUM INVESTMENT ADVISORS | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 1,335 | -799 | -37.44% | 2,000 | Jun 30, 2024 |
As of Jun 30 2024, Ocuphire Pharma's biggest institutional seller is MAI CAPITAL MANAGEMENT. The company sold -0.22M shares of OCUP, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAI CAPITAL MANAGEMENT | - | - | - | -223,970 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -65,911 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -40,814 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -36,628 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -19,868 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -17,752 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -17,400 | -100.00% | - | Jun 30, 2024 |
| LINCOLN NATIONAL CORP | - | - | - | -11,900 | -100.00% | - | Jun 30, 2024 |
| SUMMIT TRAIL ADVISORS, LLC | - | - | - | -10,545 | -100.00% | - | Jun 30, 2024 |
| TOTH FINANCIAL ADVISORY CORP | - | - | - | -1,001 | -100.00% | - | Jun 30, 2024 |
| OPTIMUM INVESTMENT ADVISORS | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| NBC SECURITIES, INC. | - | - | - | -600 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Ocuphire Pharma's largest sold out institutional shareholder by shares sold is MAI CAPITAL MANAGEMENT, sold -0.22M shares, valued at -, as of undefined.
Ocuphire Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.07% | 173,336 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 27,073 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 26,676 | - | - | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.01% | 78,851 | -49,600 | -38.61% | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 964,762 | -224,547 | -18.88% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 213,529 | 14,425 | 7.24% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 21,645 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 66,391 | 6,134 | 10.18% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 5,599 | - | - | Jan 31, 2024 |
| RBC FUNDS TRUST | 0.00% | 15,400 | - | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 5,934 | -840 | -12.40% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,216 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,152 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 3,498 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 47,122 | 2,283 | 5.09% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,932 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 241 | - | - | Mar 31, 2024 |
Ocuphire Pharma's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 173.34K shares, compromising 0.07% of its total assets.
Ocuphire Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 38 | -24.00% |
| 31 Mar, 24 | 50 | -3.85% |
| 31 Dec, 23 | 52 | - |
| 30 Sep, 23 | 52 | -3.70% |
| 30 Jun, 23 | 54 | 28.57% |
| 31 Mar, 23 | 42 | 16.67% |
| 31 Dec, 22 | 36 | 2.86% |
| 30 Sep, 22 | 35 | -5.41% |
| 30 Jun, 22 | 37 | -2.63% |
| 31 Mar, 22 | 38 | 2.70% |
| 31 Dec, 21 | 37 | 19.35% |
| 30 Sep, 21 | 31 | 3.33% |
| 30 Jun, 21 | 30 | 42.86% |
| 31 Mar, 21 | 21 | 133.33% |
| 31 Dec, 20 | 9 | - |
As of 30 Jun 24, 38 institutions are holding Ocuphire Pharma's shares, representing a decrease of -24.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,665,139 | -21.02% |
| 31 Mar, 24 | 3,374,307 | -9.12% |
| 31 Dec, 23 | 3,712,977 | -1.47% |
| 30 Sep, 23 | 3,768,550 | 2.52% |
| 30 Jun, 23 | 3,675,843 | 6.33% |
| 31 Mar, 23 | 3,457,077 | 11.53% |
| 31 Dec, 22 | 3,099,604 | 10.26% |
| 30 Sep, 22 | 2,811,081 | 16.77% |
| 30 Jun, 22 | 2,407,424 | 17.86% |
| 31 Mar, 22 | 2,042,695 | -4.71% |
| 31 Dec, 21 | 2,143,643 | 29.09% |
| 30 Sep, 21 | 1,660,518 | 57.83% |
| 30 Jun, 21 | 1,052,084 | 15.33% |
| 31 Mar, 21 | 912,227 | -58.72% |
| 31 Dec, 20 | 2,209,593 | - |
Ocuphire Pharma (OCUP) has 2.67M shares outstanding as of 30 Jun 24, down -21.02% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.87% | 4.45% |
| 31 Mar, 24 | 15.63% | 5.21% |
| 31 Dec, 23 | 17.31% | 5.36% |
| 30 Sep, 23 | 17.98% | 5.83% |
| 30 Jun, 23 | 17.55% | 6.44% |
| 31 Mar, 23 | 16.51% | 6.83% |
| 31 Dec, 22 | 15.55% | 8.27% |
| 30 Sep, 22 | 13.71% | 9.00% |
| 30 Jun, 22 | 12.34% | 10.55% |
| 31 Mar, 22 | 10.81% | 5.19% |
| 31 Dec, 21 | 14.43% | 14.99% |
| 30 Sep, 21 | 9.81% | 16.41% |
| 30 Jun, 21 | 7.73% | 11.09% |
| 31 Mar, 21 | 8.35% | 2.04% |
| 31 Dec, 20 | 20.23% | - |
As of 30 Jun 24, Ocuphire Pharma is held by 10.87% institutional shareholders, representing a 4.45% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -47.62% |
| 31 Mar, 24 | 21 | -12.50% |
| 31 Dec, 23 | 24 | 4.35% |
| 30 Sep, 23 | 23 | -34.29% |
| 30 Jun, 23 | 35 | 66.67% |
| 31 Mar, 23 | 21 | - |
| 31 Dec, 22 | 21 | 75.00% |
| 30 Sep, 22 | 12 | -36.84% |
| 30 Jun, 22 | 19 | - |
| 31 Mar, 22 | 19 | -5.00% |
| 31 Dec, 21 | 20 | 53.85% |
| 30 Sep, 21 | 13 | -31.58% |
| 30 Jun, 21 | 19 | 18.75% |
| 31 Mar, 21 | 16 | 77.78% |
| 31 Dec, 20 | 9 | - |
11 institutional shareholders have increased their position in OCUP stock as of 30 Jun 24 compared to 21 in the previous quarter (a -47.62% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | 55.56% |
| 31 Mar, 24 | 9 | - |
| 31 Dec, 23 | 9 | -30.77% |
| 30 Sep, 23 | 13 | 44.44% |
| 30 Jun, 23 | 9 | 28.57% |
| 31 Mar, 23 | 7 | 133.33% |
| 31 Dec, 22 | 3 | -66.67% |
| 30 Sep, 22 | 9 | 50.00% |
| 30 Jun, 22 | 6 | -25.00% |
| 31 Mar, 22 | 8 | 14.29% |
| 31 Dec, 21 | 7 | - |
| 30 Sep, 21 | 7 | 250.00% |
| 30 Jun, 21 | 2 | -33.33% |
| 31 Mar, 21 | 3 | - |
| 31 Dec, 20 | - | - |
14 institutional shareholders have reduced their position in OCUP stock as of 30 Jun 24 compared to 9 in the previous quarter (a 55.56% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 38 | -24.00% | 2,665,139 | -21.02% | 10.87% | 4.45% | 11 | -47.62% | 14 | 55.56% |
| 31 Mar, 24 | 50 | -3.85% | 3,374,307 | -9.12% | 15.63% | 5.21% | 21 | -12.50% | 9 | - |
| 31 Dec, 23 | 52 | - | 3,712,977 | -1.47% | 17.31% | 5.36% | 24 | 4.35% | 9 | -30.77% |
| 30 Sep, 23 | 52 | -3.70% | 3,768,550 | 2.52% | 17.98% | 5.83% | 23 | -34.29% | 13 | 44.44% |
| 30 Jun, 23 | 54 | 28.57% | 3,675,843 | 6.33% | 17.55% | 6.44% | 35 | 66.67% | 9 | 28.57% |
| 31 Mar, 23 | 42 | 16.67% | 3,457,077 | 11.53% | 16.51% | 6.83% | 21 | - | 7 | 133.33% |
| 31 Dec, 22 | 36 | 2.86% | 3,099,604 | 10.26% | 15.55% | 8.27% | 21 | 75.00% | 3 | -66.67% |
| 30 Sep, 22 | 35 | -5.41% | 2,811,081 | 16.77% | 13.71% | 9.00% | 12 | -36.84% | 9 | 50.00% |
| 30 Jun, 22 | 37 | -2.63% | 2,407,424 | 17.86% | 12.34% | 10.55% | 19 | - | 6 | -25.00% |
| 31 Mar, 22 | 38 | 2.70% | 2,042,695 | -4.71% | 10.81% | 5.19% | 19 | -5.00% | 8 | 14.29% |
| 31 Dec, 21 | 37 | 19.35% | 2,143,643 | 29.09% | 14.43% | 14.99% | 20 | 53.85% | 7 | - |
| 30 Sep, 21 | 31 | 3.33% | 1,660,518 | 57.83% | 9.81% | 16.41% | 13 | -31.58% | 7 | 250.00% |
| 30 Jun, 21 | 30 | 42.86% | 1,052,084 | 15.33% | 7.73% | 11.09% | 19 | 18.75% | 2 | -33.33% |
| 31 Mar, 21 | 21 | 133.33% | 912,227 | -58.72% | 8.35% | 2.04% | 16 | 77.78% | 3 | - |
| 31 Dec, 20 | 9 | - | 2,209,593 | - | 20.23% | - | 9 | - | - | - |
Ocuphire Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of OCUP was made by Jayagopal Ashwath on May 24 2024, buying 3,500 shares at $1.76 per share (worth $6.18K).
Ocuphire Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 16 | - | - |
| Q1 2024 | 15 | 3 | 500.00% |
| Q4 2023 | 7 | - | - |
| Q2 2023 | 16 | 6 | 266.67% |
| Q1 2023 | 12 | 1 | 1200.00% |
| Q4 2022 | 3 | 3 | 100.00% |
| Q3 2022 | 6 | 1 | 600.00% |
| Q2 2022 | 14 | - | - |
| Q1 2022 | 5 | - | - |
| Q4 2021 | 4 | - | - |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 8 | 4 | 200.00% |
| Q4 2020 | 47 | 1 | 4700.00% |
| Q2 2019 | 6 | - | - |
| Q1 2019 | 9 | 2 | 450.00% |
| Q4 2018 | 2 | - | - |
| Q2 2018 | 4 | - | - |
| Q1 2018 | 11 | - | - |
| Q3 2017 | 1 | - | - |
| Q2 2017 | 6 | 2 | 300.00% |
16 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ocuphire Pharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | - | - |
| Q1 2024 | 3 | - | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 2 | - | - |
| Q2 2021 | - | - | - |
| Q4 2020 | 18 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | 4 | - | - |
| Q4 2018 | - | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | - | - | - |
| Q3 2017 | - | - | - |
| Q2 2017 | - | 1 | - |
As of Q2 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Ocuphire Pharma's stocks.
Ocuphire Pharma Peer Ownership
| Ticker | Company |
|---|---|
| CKPT | Checkpoint Therapeutics, Inc. |
| EYPT | EyePoint Pharmaceuticals, Inc. |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. |
| FBIO | Fortress Biotech, Inc. |
| RIGL | Rigel Pharmaceuticals, Inc. |
| RNAZ | TransCode Therapeutics, Inc. |
| SLS | SELLAS Life Sciences Group, Inc. |
| KOD | Kodiak Sciences Inc. |
| EYEN | Eyenovia, Inc. |
| MBIO | Mustang Bio, Inc. |
| CGTX | Cognition Therapeutics, Inc. |
OCUP Ownership FAQ
Who Owns Ocuphire Pharma?
Ocuphire Pharma is owned by institutional shareholders (10.87%), insiders (7.33%), and public (81.80%). The largest institutional shareholder of Ocuphire Pharma is VANGUARD GROUP INC (4.05% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.07% of total shares).
Who are the major institutional shareholders of Ocuphire Pharma?
Ocuphire Pharma's major institutional shareholders are VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RICE HALL JAMES & ASSOCIATES, LLC, RICHMOND BROTHERS, INC., and BRIDGEWAY CAPITAL MANAGEMENT, LLC. The top five shareholders own together 7.49% of the company's share outstanding.
How many Ocuphire Pharma shareholders are there?
As of Jun 2024, there are 38 institutional shareholders of Ocuphire Pharma.
What percentage of Ocuphire Pharma is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 992.2K shares of Ocuphire Pharma, representing 4.05% of the company's total shares outstanding, valued at $1.52M (as of Jun 2024).
What percentage of Ocuphire Pharma is owned by GEODE CAPITAL MANAGEMENT, LLC?
As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 265.85K shares of Ocuphire Pharma (OCUP), compromising 1.08% of the company, valued at $406.84K.
What percentage of Ocuphire Pharma is owned by RICE HALL JAMES & ASSOCIATES, LLC?
RICE HALL JAMES & ASSOCIATES, LLC is the third largest holder of Ocuphire Pharma. The company owns 223.59K of the company's shares outstanding (worth $342.09K).